Hemophilia B With Intracranial Hemorrhage Rehabilitation in High-Dependency Unit: A Case Report. [PDF]
Feng X, Zhu H, Han L, Xu H, He L.
europepmc +1 more source
Chinese guidance for the clinical application of adeno-associated virus vector-based gene therapy for hemophilia B (2025). [PDF]
Xue F +25 more
europepmc +1 more source
Optimization of hemophilia B treatment via population PK modeling of rIX-FP, including a 3-week regimen. [PDF]
Terasaka N, Mckeand W.
europepmc +1 more source
CRISPR/Cas9 mediated generation of zebrafish f9a mutant as a model for hemophilia B. [PDF]
Dhinoja S +4 more
europepmc +1 more source
China's first approved gene therapy for hemophilia B: A new era for global AAV-based treatments. [PDF]
Wei H, Xiao W, Dai J.
europepmc +1 more source
Extravascular factor IX after gene therapy in hemophilia B, does it matter? [PDF]
Van Thillo Q, Hermans C.
europepmc +1 more source
<i>F9</i> missense variant hot spots associated with qualitative protein defects causing hemophilia B. [PDF]
van Duijl TT +10 more
europepmc +1 more source
Etranacogene dezaparvovec in people with hemophilia B with preexisting adeno-associated virus 5 neutralizing antibodies: 4-year subgroup results from the HOPE-B trial. [PDF]
Klamroth R +16 more
europepmc +1 more source
Second gene therapy for hemophilia B approved: More answers or questions? [PDF]
Kaczmarek R, Pierce GF.
europepmc +1 more source

